Cyclin-Dependent Kinase 4/6 Inhibitors, Margetuximab, Trastuzumab Deruxtecan, and Tyrosine Kinase Inhibitors Have Shown Promising Results
William Ray Stevens, PharmD Candidate
Advertisement
Articles by William Ray Stevens, PharmD Candidate
Advertisement
Latest Updated Articles
What Are the Newest Breast Cancer Treatment Options?Published: September 22nd 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Estradiol-Containing MHT May Impact Alzheimer Disease-Related Biomarkers in Postmenopausal Women
2
World Standards Week 2025: Advancing Quality and Patient Safety Standards to Shape Pharmacy Practice and Innovation
3
CHEST 2025: Exploring the Link Between GLP-1 Receptor Agonists, Type 2 Diabetes, and Asthma Risk
4
MHT Use Can Affect Cognitive Health Depending on Administration Method
5
